000 01251 a2200373 4500
005 20250512034249.0
264 0 _c19870217
008 198702s 0 0 ita d
022 _a0393-1978
040 _aNLM
_beng
_cNLM
100 1 _aChimienti, M
245 0 0 _a[Electrophysiologic effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation].
_h[electronic resource]
260 _bCardiologia (Rome, Italy)
_cFeb 1986
300 _a155-61 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnilides
_xadministration & dosage
650 0 4 _aAnti-Arrhythmia Agents
_xadministration & dosage
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aEncainide
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aMale
650 0 4 _aWolff-Parkinson-White Syndrome
_xdrug therapy
700 1 _aMoizi, M
700 1 _aSalerno, J A
700 1 _aKlersy, C
700 1 _aMarangoni, E
700 1 _aPrevitali, M
700 1 _aMontemartini, C
700 1 _aBobba, P
773 0 _tCardiologia (Rome, Italy)
_gvol. 31
_gno. 2
_gp. 155-61
999 _c3104226
_d3104226